F-group (family)
206.1.2.2 PIP5K
Ligands and drugs
307
Member domains
77
with ligand contacts (≤ 4 Å)
25.1% of members
66
with DrugDomain annotations
21.5% of members
44
with a DrugBank compound
14.3% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 206.1.2.2 belongs to X-group 206 Protein kinase/SAICAR synthase/ATP-grasp, which binds 10.2 ligand superclasses per 20 proteins, broader than 96% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00131 | AMP | Adenosine phosphate | 9 |
| DB01972 | 5GP | Guanosine-5'-Monophosphate | 9 |
| DB02082 | GNP | Phosphoaminophosphonic acid guanylate ester | 4 |
| DB00171 | ATP | ATP | 2 |
| DB12010 | — | Fostamatinib | 2 |
| DB09073 | LQQ | Palbociclib | 1 |
| DB11068 | SE4 | Selenic acid | 1 |
| DB12062 | IBI | Volasertib | 1 |
| DB16107 | R78 | BI 2536 | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ANP | PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER | 10 |
| 5GP | GUANOSINE-5'-MONOPHOSPHATE | 9 |
| AMP | ADENOSINE MONOPHOSPHATE | 9 |
| DVF | 5-methyl-2-(2-propan-2-ylphenyl)-~{N}-(pyridin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine | 6 |
| IDP | INOSINE-5'-DIPHOSPHATE | 6 |
| CZC | [(2~{R},3~{S},4~{R},5~{R})-5-[2,6-bis(oxidanylidene)-3~{H}-purin-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methyl phosphono hydrogen phosphate | 5 |
| GNP | PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER | 4 |
| MNmetal | MANGANESE (II) ION | 4 |
| CZF | [[(2~{R},3~{S},4~{R},5~{R})-5-[2,6-bis(oxidanylidene)-3~{H}-purin-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate | 3 |
| CZU | [[(2~{R},3~{S},4~{R},5~{R})-3,4-bis(oxidanyl)-5-(6-oxidanylidene-1~{H}-purin-9-yl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate | 3 |
| A1EN5 | ~{N}-[5-(4-oxidanylidene-3-propyl-quinazolin-6-yl)pyridin-2-yl]pentanamide | 2 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 2 |
| CAmetal | CALCIUM ION | 2 |
| CX0 | [(2~{R},3~{S},4~{R},5~{R})-5-[2,6-bis(azanyl)purin-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methyl phosphono hydrogen phosphate | 2 |
| CXC | [[(2~{R},3~{S},4~{R},5~{R})-5-[2,6-bis(azanyl)purin-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate | 2 |
| N51 | 4-{[(2E)-4-(dimethylamino)but-2-enoyl]amino}-N-(3-{[6-(1H-indol-3-yl)pyrimidin-4-yl]amino}phenyl)benzamide | 2 |
| OYZ | (2~{R})-2-[[3-cyano-2-[4-(2-ethoxyphenyl)phenyl]-5,8-dihydro-1,7-naphthyridin-4-yl]amino]propanoic acid | 2 |
| OZ5 | (2~{R})-2-[[3-cyano-2-[4-(2-fluoranyl-3-methyl-phenyl)phenyl]-1,7-naphthyridin-4-yl]amino]butanoic acid | 2 |
| P4Z | (2~{R})-2-[[2-[4-(3-chloranyl-2-fluoranyl-phenyl)phenyl]-3-cyano-1,7-naphthyridin-4-yl]amino]butanamide | 2 |
| QZR | 6-methyl-~{N}-(4-methylsulfonylphenyl)thieno[2,3-d]pyrimidin-4-amine | 2 |